Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (111-120 of 1,339) with videos related to

Pageof 134
Sort By:
Expert Opinion on Investigational Drugs|November 11, 2017
Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)Philip A Thompson, Jan A Burger
Leukemia & Lymphoma|February 22, 2013
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)Jan A Burger, Joseph J Buggy
International Journal of Cancer|March 12, 2014
The value of improving failures within a cervical cancer screening program: an example from NorwayEmily A Burger, Jane J Kim
Therapeutische Umschau. Revue Therapeutique|February 1, 1980
[Amiodarone and thyroid function]B Liechti, A Burger, C Ferrero
Seminars in Cancer Biology|September 28, 2011
The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapiesJan A Burger, Richard J Ford
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2022
Highlights of the 34th EANM Annual Congress 2021, 2nd virtual edition: "FROM HAMBURG WITH LOVE"Nathalie L Albert, Irene A Burger
Cancer Research|May 27, 2010
BCR-mediated decrease of CXCR4 and CD62L in CLLMaite P Quiroga, Jan A Burger
Revue Medicale De La Suisse Romande|July 28, 1999
[Heart and thyroid]V Col, S Simon, A Burger
Blood|February 4, 2017
HSP90, a chaperone that can make you SYKElisa Ten Hacken, Jan A Burger
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1990
Ghosts of chromaffin granules accumulate biogenic amines according to a "pump and leak system" without contribution of carrier-mediated effluxW Michalke, R Langer, A Burger
Pageof 134

Showing results (111-120 of 1,339) with videos related to

Sort By:
Pageof 134
Expert Opinion on Investigational Drugs|November 11, 2017
Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)Philip A Thompson, Jan A Burger
Leukemia & Lymphoma|February 22, 2013
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)Jan A Burger, Joseph J Buggy
International Journal of Cancer|March 12, 2014
The value of improving failures within a cervical cancer screening program: an example from NorwayEmily A Burger, Jane J Kim
Therapeutische Umschau. Revue Therapeutique|February 1, 1980
[Amiodarone and thyroid function]B Liechti, A Burger, C Ferrero
Seminars in Cancer Biology|September 28, 2011
The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapiesJan A Burger, Richard J Ford
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2022
Highlights of the 34th EANM Annual Congress 2021, 2nd virtual edition: "FROM HAMBURG WITH LOVE"Nathalie L Albert, Irene A Burger
Cancer Research|May 27, 2010
BCR-mediated decrease of CXCR4 and CD62L in CLLMaite P Quiroga, Jan A Burger
Revue Medicale De La Suisse Romande|July 28, 1999
[Heart and thyroid]V Col, S Simon, A Burger
Blood|February 4, 2017
HSP90, a chaperone that can make you SYKElisa Ten Hacken, Jan A Burger
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1990
Ghosts of chromaffin granules accumulate biogenic amines according to a "pump and leak system" without contribution of carrier-mediated effluxW Michalke, R Langer, A Burger
Pageof 134